Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 15 May 1998:
Vol. 280. no. 5366, p. 1004
DOI: 10.1126/science.280.5366.1004
Prev | Table of Contents | Next

News & Comment

ALZHEIMER'S RESEARCH:
A Clash Over Testing for Alzheimer's Disease

Eliot Marshall

In October a bioethics panel issued a draft opinion stating that although testing for rare Alzheimer's genes--dominant mutations that almost invariably lead to early-onset disease--"may be appropriate" in the small number of families at risk, for the vast majority who get the disease later in life, "neither predictive nor diagnostic genetic testing for susceptibility genes (e.g., APOE) should be encouraged at this time." But the discoverer of the APOE-Alzheimer's connection, Duke University neurologist Allen Roses, claims that physicians correctly identify Alzheimer's in only 60% to 70% of patients and that testing APOE could raise that accuracy rate to 95%.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Genetic Testing and its Implications: Human Genetics Researchers Grapple with Ethical Issues.
I. Rabino (2003)
Science Technology Human Values 28, 365-402
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)